Related Experiment Video
Updated: Sep 27, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
[Unstable angina in the elderly]
1Service de cardiologie, groupe hospitalier Bichat-Claude Bernard, 46, rue Henri Huchard, 75018 Paris, France. dominique.himbert@bch.ap-hop-paris.fr
Insights
Elderly patients with acute coronary syndromes benefit most from early revascularization and specific treatments like eptifibatide. Tailored management focusing on the culprit vessel improves outcomes in this high-risk group.
Area of Science:
- Cardiology
- Geriatric Medicine
- Pharmacology
Context:
- Unstable angina and acute coronary syndromes without persistent ST-segment elevation (NSTEMI) are prevalent in the elderly.
- Age is the strongest predictor of in-hospital mortality in NSTEMI patients.
- Interventional strategies show significant clinical benefit, particularly in older adults.
Purpose:
- To evaluate the efficacy of interventional strategies and pharmacological treatments in elderly patients with NSTEMI.
- To highlight the importance of individualized treatment approaches considering comorbidities and triggering factors.
- To emphasize the goal of achieving optimal myocardial revascularization, prioritizing culprit vessel intervention.
Summary:
- The clinical benefit of interventional strategies like those in FRISC II and TACTICS TIMI 18 is most pronounced in elderly NSTEMI patients.
- Eptifibatide, a glycoprotein IIb/IIIa inhibitor, demonstrates increased efficacy in older individuals undergoing revascularization.
- Management requires careful consideration of individual factors, with a focus on percutaneous coronary intervention for the culprit vessel.
Impact:
- Treatment strategies must be individualized for elderly NSTEMI patients, considering comorbidities.
- Coronary artery bypass grafting is generally reserved for lesions unsuitable for percutaneous coronary intervention.
- Maximal clinical improvement is observed in elderly patients presenting with severe NSTEMI symptoms.
Abstract:
Unstable angina and acute coronary syndromes without persistent ST-segment elevation are frequent and their prognosis is poor in the elderly. Indeed, age is the most powerful predictor of in-hospital mortality in this setting. The clinical benefit of interventional strategies, as demonstrated by FRISC II and TACTICS TIMI 18 studies, seems to be most important in this age subset. PURSUIT trial demonstrates that the efficacy of eptifibatide, a IIb/IIIa platelet receptor inhibitor, increases in elderly patients who simultaneously undergo revascularization interventions. Individual application of such treatment strategies may be difficult. Potential triggering factors of unstable angina and comorbidities have to be taken into account, and the overall management should be highly individualized in elderly patients. The aim remains to achieve appropriate myocardial revascularization, as often as possible by focusing coronary angioplasty on the culprit vessel. Coronary surgery generally should be reserved for coronary lesions which are not suitable for percutaneous revascularization. Clinical improvement is maximal in patients with severe initial presentation.
Related Concept Videos
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina I: Introduction
Angina V: Nursing Management
Angina IV: Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
